Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cancervax Corp (CNVX) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cancervax Corp. Table 2 shows the detailed insider transactions. This company's CIK number is 1131907.
Total stock buying since 2010: $349,737,653.
Total stock sales since 2010: $985,539.
Total stock option exercises since 2010: $297,116.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2012 | 31,792,023 | $349,712,253 | 0 | $0 | 0 | $0 |
| 2011 | 5,000 | $25,400 | 151,150 | $768,339 | 151,150 | $294,671 |
| 2010 | 0 | $0 | 30,000 | $217,200 | 757 | $2,445 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2012-03 | 31,792,023 | $349,712,253 | 0 | $0 | 0 | $0 |
| 2011-03 | 5,000 | $25,400 | 151,150 | $768,339 | 151,150 | $294,671 |
| 2010-10 | 0 | $0 | 0 | $0 | 757 | $2,445 |
| 2010-06 | 0 | $0 | 30,000 | $217,200 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-03-07 | Armstrong Acquisition Corp. (10% Owner) | Buy | 27,132,931 | 11.00 | 298,462,241 |
| 2012-03-06 | Armstrong Acquisition Corp. (10% Owner) | Buy | 2,170,710 | 11.00 | 23,877,810 |
| 2012-03-05 | Armstrong Acquisition Corp. (10% Owner) | Buy | 2,035,994 | 11.00 | 22,395,934 |
| 2012-03-02 | Armstrong Acquisition Corp. (10% Owner) | Buy | 452,388 | 11.00 | 4,976,268 |
| 2011-03-16 | Reisenauer Mark L (SVP, Chief Commercial Officer) | Sale | 40,050 | 5.01 | 200,730 |
| 2011-03-16 | Reisenauer Mark L (SVP, Chief Commercial Officer) | Option Ex | 40,050 | 1.86 | 74,693 |
| 2011-03-16 | Johann Peter (Director) | Buy | 5,000 | 5.08 | 25,400 |
| 2011-03-15 | Reisenauer Mark L (SVP, Chief Commercial Officer) | Sale | 111,100 | 5.11 | 567,609 |
| 2011-03-15 | Reisenauer Mark L (SVP, Chief Commercial Officer) | Option Ex | 111,100 | 1.98 | 219,978 |
| 2010-10-15 | Carter Michael G (Director) | Option Ex | 757 | 3.23 | 2,445 |
| 2010-06-16 | Hale David F (Director) | Sale | 30,000 | 7.24 | 217,200 |
Insider trading activities including stock purchases, stock sales, and option exercises of CNVX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cancervax Corp (symbol CNVX, CIK number 1131907) see the Securities and Exchange Commission (SEC) website.